52 related articles for article (PubMed ID: 38452923)
1. Remission of hepatocellular carcinoma with arginine depletion induced by systemic release of endogenous hepatic arginase due to transhepatic arterial embolisation, augmented by high-dose insulin: arginase as a potential drug candidate for hepatocellular carcinoma.
Cheng PN; Leung YC; Lo WH; Tsui SM; Lam KC
Cancer Lett; 2005 Jun; 224(1):67-80. PubMed ID: 15911102
[TBL] [Abstract][Full Text] [Related]
2. Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion.
Cheng PN; Lam TL; Lam WM; Tsui SM; Cheng AW; Lo WH; Leung YC
Cancer Res; 2007 Jan; 67(1):309-17. PubMed ID: 17210712
[TBL] [Abstract][Full Text] [Related]
3. A phase II clinical study on the efficacy and predictive biomarker of pegylated recombinant arginase on hepatocellular carcinoma.
Chan SL; Cheng PNM; Liu AM; Chan LL; Li L; Chu CM; Chong CCN; Lau YM; Yeo W; Ng KKC; Yu SCH; Mok TSK; Chan AWH
Invest New Drugs; 2021 Oct; 39(5):1375-1382. PubMed ID: 33856599
[TBL] [Abstract][Full Text] [Related]
4. Treating liver cancer through arginine depletion.
Prasad YR; Anakha J; Pande AH
Drug Discov Today; 2024 Apr; 29(4):103940. PubMed ID: 38452923
[TBL] [Abstract][Full Text] [Related]
5. Targeted cellular metabolism for cancer chemotherapy with recombinant arginine-degrading enzymes.
Kuo MT; Savaraj N; Feun LG
Oncotarget; 2010 Aug; 1(4):246-51. PubMed ID: 21152246
[TBL] [Abstract][Full Text] [Related]
6. Arginine deprivation in cancer therapy.
Feun LG; Kuo MT; Savaraj N
Curr Opin Clin Nutr Metab Care; 2015 Jan; 18(1):78-82. PubMed ID: 25474015
[TBL] [Abstract][Full Text] [Related]
7. Human arginase I: a potential broad-spectrum anti-cancer agent.
Anakha J; Prasad YR; Sharma N; Pande AH
3 Biotech; 2023 May; 13(5):159. PubMed ID: 37152001
[TBL] [Abstract][Full Text] [Related]
8. Arginine depriving enzymes: applications as emerging therapeutics in cancer treatment.
Kumari N; Bansal S
Cancer Chemother Pharmacol; 2021 Oct; 88(4):565-594. PubMed ID: 34309734
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis and current strategies of therapeutic arginine depletion for cancer.
Fultang L; Vardon A; De Santo C; Mussai F
Int J Cancer; 2016 Aug; 139(3):501-9. PubMed ID: 26913960
[TBL] [Abstract][Full Text] [Related]
10. Targeting arginine metabolism pathway to treat arginine-dependent cancers.
Qiu F; Huang J; Sui M
Cancer Lett; 2015 Aug; 364(1):1-7. PubMed ID: 25917076
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]